The COVERT protocol was designed to assess, through a longitudinal analysis, the level ofantibodies present in the serum of patients with COVID-19, the duration and thepersistence of the humoral response in correlation with the severity of the disease.
Not Provided
Biological: blood sample
A sample of blood (1mL) was taken
Inclusion Criteria:
- Age ≥18 years old,
- Patient whose Covid-19 diagnosis has been confirmed by RT-PCR test (SARS-CoV-2
positive) from a nasopharyngeal swab/broncho alveolar lavage
- Patient whose severity of Covid-19 required hospital treatment
- Patient whose Covid-19 form is defined as moderate (stay in general ward) or severe
(stay in ICU), based on the clinical evaluation conducted by the doctor
- Patient agreeing to participate in the study and having signed the informed consent.
Exclusion Criteria:
- Adult person subject to legal protection,
- Pregnant, parturient or breastfeeding woman
- Person not affiliated to a social security scheme or not beneficiary of such a
scheme
- Person subject to a safeguard measure
- Person deprived of liberty by a judicial or administrative decision and woman
hospitalized without consent under Articles L.3212-1 and 3213-1, which do not fall
under Article L.1122-8 of the Public Health Code.
CH ANnecy-GEnevois (CHANGE)
Metz-tessy, Rhône Alpes, France
Not Provided